BLOG
Injunctive Relief Agreement Creates Sweeping Guidance for Suspicious Order Monitoring
Injunctive Relief Agreement Creates Sweeping Guidance for Suspicious Order Monitoring Background The Opioid Epidemic is one of the greater tragedies to occur within the last few decades and will forever be a black mark on the drug supply chain. Although it...
Recent Articles
FDA Proposed Rules Review, Part 2 of 4: 3PL Licensing & Organization Oversight
FDA Proposed Rules Review, Part 2 of 4: 3PL Licensing Standards & Approved Organizations Oversight FDA Proposed Rules. In this second part of...
Nevada to Require Nonresident Pharmacists To Obtain Licensure
Nevada to Require Nonresident Pharmacists To Obtain Licensure Nevada Reinterpreted NRS 639.100(1)(a) to Require Nonresident Pharmacist Licensure...
Puerto Rico Product Registration: Undocumented Rule and Enforcement Change
Puerto Rico Product Registration: Undocumented Rule and Enforcement Change Understanding Registration Basics Pursuant to Puerto Rico Chapter 5,...
The Complexities and Application of Drug Takeback Programs
The Complexities and Application of Drug Takeback Programs Pre-Article Comment: For those Health Care Practitioners and Pharmacies that are not...
Manufacturers Don’t Forget: Virginia Drug Pricing Reports are Due April 1st
Manufacturers Don’t Forget: Virginia Drug Pricing Reports are Due April 1st March 2021, Virginia passed the Prescription Drug Price Transparency...
Do Drug Price Transparency Laws Need to Explicitly Define Reporting Entities?
Do Drug Price Transparency Laws Need to Explicitly Define Reporting Entities? With the wave of 2021 passed Drug Price Transparency “DPT” laws now...
